30September

PFS Partner Hyris Secures UK Triumph with Canadian Government 90-Minute COVID-19 Testing Megadeal

PFS Partner Hyris Secures UK Triumph with Canadian Government 90-Minute COVID-19 Testing Megadeal

Hyris bCUBE based test kit is the only authorised medical device approved for human tests in Point of Care currently commercially available in Canada. Hyris Ltd. now focuses on supporting Canada in fully facing the new virus escalation.

(London, UK, Wednesday, September 30th, 2020).

The Government of Canada has issued a significant approval for PFS’ London based client Hyris for rapid Coronavirus testing, which will be deployed across the country as Hyris “bCUBE” has been approved for human tests by Health Canada scientists; as such, the bCUBE is the only authorised medical device, commercially available in Canada for diagnostic use related to COVID-19, which can provide a certified ‘point of care’ solution. The bCUBE adopts “gold standard” genetic sequences in line with CDC and WHO guidelines: it can provide human COVID-19 test results at the same level as a hospital laboratory, without the requirement for a lab, also reducing the time needed for diagnosis.

The technology features an Internet of Things (IoT) architecture, meaning it can easily be scaled at speed to help millions of people to receive a reliable Coronavirus test result in under 2 hours. Hyris says it can profoundly positively impact satellite healthcare facilities, communities and companies worldwide that are currently starved of access to this type of disruptive solution.

One time aspiring astronaut turned tech entrepreneur, Stefano Lo Priore, Founder & CEO at Hyris, said: “The greater London area is a global hub for Biotechnology and Finance, and we feel we are well-positioned with our local partners to support the worldwide expansion of our user network. This authorization from the Canadian Government is an important confirmation for us as well as for PFS, which has been a trusted partner in this adventure for several years.”

Lee Britton, CCO at PFS (a company of EML), explained: “It's an honour to stand with our High Tech partner Hyris and our good friend Stefano as he enables testing heroes across Canada, and soon here in Europe, to fight COVID with an invaluable diagnostic solution. As we continue to engage with all kinds of inspirational tech thought leaders requiring smart payment solutions, we never lose sight of the positive impact companies like Hyris can have on countries around the world, and closer to home. Soon, Stefano and his team will be live in more than 12 nations.''

In the future, thanks to its platform, Hyris believes the units will generate data that when analysed collectively, may give next-level insights into pandemic developments and feed into AI algorithms that could help to best manage a global response.

 

Read the full article HERE

Posted in Technology

Newsletter

Subscribe our newsletter for periodical updates about our technologies

Address


Lower Ground Floor
One George Yard
EC3V 9DF - London, UK
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Social



Copyright © 2019 - Hyris Ltd // Powered by Amodeo Design